GLENDA THOMS: Open Payments
NPI 1902856354 · HIRAM, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 13 payments from 11 companies in 2025. Trend: 2023 $253 · 2024 $383 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 2 | $31 |
| SANOFI-AVENTIS U.S. LLC | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $28 |
| Novo Nordisk Inc | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Dexcom, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| BIOTRONIK NRO, Inc. | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: MOUNJARO, TZIELD, LEQVIO, Kerendia, Dexcom G6 Transmitter, UBRELVY, Prospera, SHINGRIX.
Industry payments across GA — which companies pay providers there.
